Condition: PCOS · Cardiovascular Disease · Atherosclerotic Cardiovascular Disease · Sponsor: University of Alberta
Women with Polycystic Ovary Syndrome (PCOS) have high testosterone levels which is associated with altered insulin-glucose metabolism and an adverse blood lipid profile, predisposing them to the development of Type II Diabetes and Cardiovascular Disease (CVD). This study will investigate the use of dietary fish oil supplementation as a safe and effective intervention, and as an adjunct therapy to standard of care treatment with metformin to improve heart health, blood lipids and insulin-glucose metabolism in women with PCOS, and those with PCOS and Type 2 Diabetes.
This description comes directly from the study's public registry record.
Donna Vine, PhD · 780-492-4393 · dvine@ualberta.ca
Always discuss trial participation with your own doctor first.
| Human Nutrition Research Unit - Li Ka Shing Health Research Center | Edmonton, Alberta, Canada | Recruiting |
| Mazankowski Alberta Heart Institute | Edmonton, Alberta, Canada | Recruiting |
| University of Alberta Hospital - Division of Endocrinology | Edmonton, Alberta, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06424860